These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26639242)

  • 61. Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue.
    Stephan C; Jung M; Rabenhorst S; Kilic E; Jung K
    Clin Chem Lab Med; 2015 Jun; 53(7):1109-18. PubMed ID: 25720086
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Highly increased maspin expression corresponds with up-regulation of miR-21 in endometrial cancer: a preliminary report.
    Torres A; Torres K; Paszkowski T; Radej S; Staśkiewicz GJ; Ceccaroni M; Pesci A; Maciejewski R
    Int J Gynecol Cancer; 2011 Jan; 21(1):8-14. PubMed ID: 21330826
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Exosomal miR-675 from metastatic osteosarcoma promotes cell migration and invasion by targeting CALN1.
    Gong L; Bao Q; Hu C; Wang J; Zhou Q; Wei L; Tong L; Zhang W; Shen Y
    Biochem Biophys Res Commun; 2018 Jun; 500(2):170-176. PubMed ID: 29626470
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hydrogel-based hybridization chain reaction (HCR) for detection of urinary exosomal miRNAs as a diagnostic tool of prostate cancer.
    Kim J; Shim JS; Han BH; Kim HJ; Park J; Cho IJ; Kang SG; Kang JY; Bong KW; Choi N
    Biosens Bioelectron; 2021 Nov; 192():113504. PubMed ID: 34298498
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Detection of MCM5 as a novel non-invasive aid for the diagnosis of endometrial and ovarian tumours.
    Stockley J; Akhand R; Kennedy A; Nyberg C; Crosbie EJ; Edmondson RJ
    BMC Cancer; 2020 Oct; 20(1):1000. PubMed ID: 33059604
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Exosomal MiRNAs in Pediatric Cancers.
    Galardi A; Colletti M; Di Paolo V; Vitullo P; Antonetti L; Russo I; Di Giannatale A
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31533332
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Role of miRNAs in the Development, Proliferation, and Progression of Endometrial Cancer.
    Bogaczyk A; Zawlik I; Zuzak T; Kluz M; Potocka N; Kluz T
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511248
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Diagnostic value of microRNA panel in endometrial cancer: A systematic review.
    Donkers H; Bekkers R; Galaal K
    Oncotarget; 2020 May; 11(21):2010-2023. PubMed ID: 32523655
    [TBL] [Abstract][Full Text] [Related]  

  • 69. MicroRNA, a Promising Biomarker for Breast and Ovarian Cancer: A Review.
    Akram F; Atique N; Haq IU; Ahmed Z; Jabbar Z; Nawaz A; Aqeel A; Akram R
    Curr Protein Pept Sci; 2021; 22(8):599-619. PubMed ID: 34102968
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Stabilization of Urinary MicroRNAs by Association with Exosomes and Argonaute 2 Protein.
    Beltrami C; Clayton A; Newbury LJ; Corish P; Jenkins RH; Phillips AO; Fraser DJ; Bowen T
    Noncoding RNA; 2015 Sep; 1(2):151-166. PubMed ID: 29861421
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Discovery and Evaluation of Extracellular MicroRNA Biomarkers in Plasma, Ascites, and Urine.
    Záveský L; Slanař O
    Methods Mol Biol; 2023; 2630():135-143. PubMed ID: 36689181
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Coiled-coil domain-containing protein-124 (Ccdc124) is a novel RNA binding factor up-regulated in endometrial, ovarian, and urinary bladder cancers.
    Arslan Ö; Soylu NK; Akillilar PT; Tazebay UH
    Cancer Biomark; 2021; 31(2):149-164. PubMed ID: 33896821
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Extracellular microRNAs in urologic malignancies: chances and challenges.
    Huang X; Liang M; Dittmar R; Wang L
    Int J Mol Sci; 2013 Jul; 14(7):14785-99. PubMed ID: 23863690
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Stability and profiling of urinary microRNAs in healthy cats and cats with pyelonephritis or other urological conditions.
    Jessen LR; Nielsen LN; Kieler IN; Langhorn R; Reezigt BJ; Cirera S
    J Vet Intern Med; 2020 Jan; 34(1):166-175. PubMed ID: 31721298
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Urinary MicroRNAs as Emerging Class of Noninvasive Biomarkers.
    Juracek J; Slaby O
    Methods Mol Biol; 2020; 2115():221-247. PubMed ID: 32006404
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Urinary miRNAs: Technical Updates.
    Raveendran S; Al Massih A; Al Hashmi M; Saeed A; Al-Azwani I; Mathew R; Tomei S
    Microrna; 2024; 13(2):110-123. PubMed ID: 38778602
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ribonucleic-acid-biomarker candidates for early-phase group detection of common cancers.
    Shajari E; Mollasalehi H
    Genomics; 2020 Jan; 112(1):163-168. PubMed ID: 30189225
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Representation analysis of miRNA from clarified urine and urine microvesicles in prostate malignancies and non-malignant neoplasms].
    Zaporozhchenko IA; Bryzgunova OE; Lekchnov EA; Osipov ID; Zaripov MM; Yurchenko YB; Yarmoschuk SV; Pashkovskaya OA; Rykova EY; Zheravin AA; Laktionov PP
    Biomed Khim; 2018 Jan; 64(1):38-45. PubMed ID: 29460833
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Panel of 12 Cell-Free MicroRNAs as Potential Biomarkers in Prostate Neoplasms.
    Konoshenko MY; Lekchnov EA; Bryzgunova OE; Zaporozhchenko IA; Yarmoschuk SV; Pashkovskaya OA; Pak SV; Laktionov PP
    Diagnostics (Basel); 2020 Jan; 10(1):. PubMed ID: 31936850
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An overview of challenges associated with exosomal miRNA isolation toward liquid biopsy-based ovarian cancer detection.
    Bhadra M; Sachan M
    Heliyon; 2024 May; 10(9):e30328. PubMed ID: 38707279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.